Latest Generics Drugs News

[Comment] Inhibition of PCSK9 in familial hypercholesterolaemiaStatins are indicated for treatment of patients with heterozygous familial hypercholesterolaemia: these drugs inhibit hepatic cholesterol synthesis and indirectly raise transcription and expression of low-density lipoprotein (LDL) receptors, resultin...

Natural Treatment and Maintenance of Prostate Enlargement with New Thermobalancing Therapy Improves Men’s Well-being in Safety States Fine TreatmentFine Treatment recommends new Thermobalancing Therapy as successful natural solution for benign prostatic hyperplasia that is also the most cost-effective prostate treatment on the market. While long-term medication courses and BPH surgeries may cost thousands of dollars, the price of Dr. Allen’s Device for Prostate Treatment under $150 makes it widely affordable. London, UK (PRWEB) May 26, 2012...

Deals Of The Week Jump Starts The Summer Reading List

High on the New York Times List of Bestsellers (in the hardcover advice & miscellaneous category) this spring has been the book “Innovation: Create Far From Home, Win Everywhere.”It’s by two well-known Dartmouth business school professors,...

Delcath raises $20 millionDrug delivery company Delcath Systems Inc. (NASDAQ:DCTH) raised $20 million through the sale of 13.3 million units at $1.50 per unit in a follow-on underwritten by Cowen; Wedbush; and Roth. Each unit comprises a share and a three-year warrant to purc...

ODAC meeting to discuss RCC imagingFDA's Oncologic Drugs Advisory Committee (ODAC) will meet on July 25 to discuss the extent of useful clinical information provided by an imaging test for clear cell renal cell carcinoma (RCC) before surgery. FDA will also review the development strat...

House to vote on PDUFA bill next weekThe U.S. House of Representatives will vote on its version of PDUFA reauthorization legislation next Wednesday, according to a memo sent to House Republicans by Majority Leader Eric Cantor (R-Va.). Cantor hopes to reach an agreement with the Senate b...

CHMP recommends Medac's generic Zometa, clears infected MabThera, seeks harmonyThe EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended for approval German firm Medac's generic version of Novartis' Zometa (Zoledronic acid). The product, Zoledronic acid medac, is a concentrate solution for.....

Albemarle to increase ibuprofen pricesBATON ROUGE, La., May 25, 2012 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global developer, manufacturer and marketer of highly engineered specialty chemicals, announced today that it will increase global prices for all grades of ibuprofen by an estimated 15% effective immediately, or as contracts allow. (Logo: http://photos.prnewswire.com/prnh/20111129/MM14279LOGO ) Albema...

Cancer Imaging In Clear Cell Renal Carcinoma Gets ODAC Attention As Pipeline FillsFDA’s Oncologic Drugs Advisory Committee will examine the extent (if any) to which the pre-surgical identification of clear cell carcinoma of the kidney using an imaging test provides useful clinical information. ASCO abstracts show considerable re...

IBD drugs may have no role in birth defectsNEW YORK (Reuters Health) - For pregnant patients with inflammatory bowel disease (IBD), the highest source of risk to the fetus may be the disease itself, and not the drugs taken for it, new data suggest.

Device May Inject Variety of Drugs Without Using NeedlesResearchers have engineered a device that delivers a tiny, high-pressure jet of medicine through the skin without the use of a hypodermic needle.

The Lin Law Firm Announces That a Securities Class Action Lawsuit Against ViroPharma Incorporated Has Been FiledLOS ANGELES, May 25, 2012 /PRNewswire/ -- The Lin Law Firm, A Professional Law Corporation, announces that a class action has been filed on behalf of investors who purchased the securities of ViroPharma Incorporated ("ViroPharma") (Nasdaq:VPHM) between December 14, 2011 and April 9, 2012 ("Class Period"). The Complaint asserts violations of the federal securities laws against ViroPharma and...

Guangdong’s 2012 Drug Procurements Show Increased Quality FocusGuangdong’s 2012 drug procurement policy will resemble its 2011 predecessor that set fixed prices for low-priced drugs and slightly raised price caps for drugs with higher production costs.

New Chinese Formulary To See More Chronic Illness MedsChina will increase the number of essential drugs for chronic diseases, according to the Ministry of Health.

15 South Korea Pharmas In Potential Battle With Pfizer Over Viagra GenericSouth Korea could become a battleground between local makers of generic drugs and Pfizer Inc. over the latter’s erectile-dysfunction drug Viagra (sildenafil) and its alleged patent protection.

Endo Health Solutions Inc. to Present at Jefferies 2012 Global Healthcare ConferenceCHADDS FORD, Pa., May 25, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate overview at the Jefferies 2012 Global Healthcare Conference on Monday, June 4, 2012 at 9:00 a.m. ET. The conference will be held in New York City. A live webcast and audio archive of the presentation will be availa...

Endo Health Solutions Inc. to Present at the Goldman Sachs 33rd Annual Global Healthcare ConferenceCHADDS FORD, Pa., May 25, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate overview at the Goldman Sachs 33rd Annual Global Healthcare Conference on Tuesday, June 5, 2012 at 2:40 p.m. PT. The conference will be held at Terranea in Rancho Palos Verdes, CA. A live webc...

New Drugs For Bad Bugs? John Rex DiscussesYesterday, several European drugmakers – including GlaxoSmithKline and Sanofi – agreed to work with academics to combat antimicrobial resistance and speed the delivery of new antibiotics. The $285 million effort, called NewDrugs4BadBugs,...

Watson Confirms Testim Patent ChallengeWatson Pharmaceuticals, Inc. has confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the FDA seeking approval to market Testosterone Gel, 1%. Watson's 1% testosterone gel product is a generi...

FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis MegluminePfizer Inc. has announced that the FDA's Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine.

India Pharmas Stiff-Arm Agency Request For Old Drug-Overcharge DataIndia’s Department of Pharmaceuticals has not received a single response from the nation’s drug makers to a February request for the amount each overcharged for its drugs, part of a dispute dating back to 1987.

Increased use of generic statins proves cost effective in AustraliaA recent study concluded that closing the statin ‘treatment gap’ using generics was cost-effective in the secondary prevention of coronary artery disease (CAD) in Australia [1].

Generics makers cannot gain access to some brand-name drugsGenerics manufacturers trying to create generics for certain drugs are having problems gaining access to samples of the brand-name drugs due to restrictions on supply put in place by FDA.

Medochemie deploys Cegedim cloud-based CRM solutionMedochemie, an international generic pharmaceutical manufacturer, has implemented Cegedim Relationship Management's cloud-based Mobile Intelligence for its Primary and Key Account Management commercial teams in Greece, Cyprus and Romania.

SOCMA's Bulk Pharmaceuticals Task Force Hails Senate Passage of FDA User Fee BillUrges the House to Follow Suit WASHINGTON, May 25, 2012 /PRNewswire-USNewswire/ -- The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates (SOCMA), today commended the Senate for approving the Food and Drug Administration Safety and Innovation Act (S. 2516), bringing the nation one step closer to a safer drug supply chain. The legi...

0 1 2 3 4 ›»

buy Generics Drugs market research data and corporate reports now Advertisement